New paper argues that Large Language Models can reveal breakthroughs humans alone cannot

Classified as: Neuro, MNI, Danilo Bzdok, Artificial intelligence, large language models
Published on: 9 Feb 2024

Researchers propose a new model for classifying Parkinson’s

 

One of the things that makes developing effective treatments for Parkinson’s disease so challenging is its complexity. While some forms are caused by genetics, others have environmental factors, and patients can show a wide range of symptoms of varying severity. Diagnosis of Parkinson’s is also currently made very late, after the disease may have been in the brain for a decade or more.

Classified as: Ron Postuma, Parkinson's disease, genetics, Neuro
Published on: 23 Jan 2024

The Centre for Addiction and Mental Health (CAMH) joins the Tanenbaum Open Science Institute alliance in a partnership to open research practices

Classified as: TOSI, open science, Tanenbaum Open Science Institute, Centre for Addiction and Mental Health, Neuro
Category:
Published on: 12 Dec 2023

Machine learning tutors affect learners in unforeseen ways, both positive and negative

Virtual reality simulators can help learners improve their technical skills faster and with no risk to patients. In the field of neurosurgery, they allow medical students to practice complex operations before using a scalpel on a real patient. When combined with artificial intelligence, these tutoring systems can offer tailored feedback like a human instructor, identifying areas where the students need to improve and making suggestions on how to achieve expert performance.

Classified as: Neuro, rolando del maestro, neurosurgery, Artificial intelligence
Published on: 19 Sep 2023

Scientists identify the first genetic marker for MS severity, opening the door to treatments for long-term disability

A study of more than 22,000 people with multiple sclerosis has discovered the first genetic variant associated with faster disease progression, which can rob patients of their mobility and independence over time.

Classified as: Neuro, Montreal Neurological Institute, MS, Multiple Sclerosis, Adil Harroud
Published on: 28 Jun 2023

Partnership with Novartis Pharmaceuticals Canada Inc. has created a faster, easier way for patients to contribute to research

 

Patients can now digitally consent to be included in The Neuro’s Open Biobank (Clinical Biospecimen Imaging and Genetic Repository) and patient registry, providing a more efficient and easier way to help patients accelerate neurological disorder research and participate in clinical trials. The new platform is financially supported by Novartis Pharmaceuticals Canada Inc.

Classified as: Neuro, MNI, Open Biobank, open science, Jason Karamchandani
Published on: 16 Jun 2023

Goal is to accelerate research and let patients know how their data is helping find treatments

A $6M grant from Brain Canada will fund the creation of a new Open Science patient registry, to share data with researchers around the world and let patients see how their data is used to develop new treatments for neurological disorders.

Classified as: Neuro, Open Biobank, Brain Canada, Guy Rouleau, Jason Karamchandani, open science
Published on: 28 Apr 2023

Thinning in the right temporo-parietal cortex and left prefrontal cortex were similar in both groups

A new study led by scientists at The Neuro (Montreal Neurological Institute-Hospital) of McGill University finds a correlation between neurodegeneration in obese people and Alzheimer’s disease (AD) patients.

Classified as: Alzheimer's disease, neuroimaging, obesity, Neuro
Published on: 31 Jan 2023

Consortium brings together hundreds of researchers from 28 networks, 11 trial units across the country

Today the Canadian Institutes of Health Research (CIHR) announced funding for a new clinical trial consortium co-chaired by Dr. Guy Rouleau, Director of The Neuro (Montreal Neurological Hospital-Institute).  

Classified as: Guy Rouleau, Accelerating Clinical Trials, Neuro, Montreal Neurological Institute
Published on: 19 Jan 2023

Discovery will improve diagnosis and open treatment possibilities for thousands of people with this debilitating neurodegenerative condition worldwide

A new study published on Dec. 14, 2022 in the New England Journal of Medicine reports the identification of a previously unknown genetic cause of a late-onset cerebellar ataxia, a discovery that will improve diagnosis and open new treatment avenues for this progressive condition.

Classified as: Neuro, Bernard Brais, genetics, ataxia
Published on: 15 Dec 2022

Software tool brings together multiple brain maps in one place

The brain is a complex organ, and no one imaging mode can catch everything that’s going on inside it. Over the years, multiple “brain maps” have emerged, each focusing on different brain processes, from metabolism to cognitive function. While these maps are important, using them in isolation limits the discoveries researchers can make from them.

Classified as: Neuro, bratislav misic, McConnell Brain Imaging Centre, brain imaging
Published on: 6 Oct 2022

Purpose is to understand post-COVID symptom evolution and impact on patients’ lives

As of Sept. 20, 2022, there have been more than 1.1 million cases of COVID-19 in Quebec. It is estimated that 10 to 30 per cent of cases will have lingering symptoms after the acute illness. This means that as many as 330,000 Quebecers may experience what’s become known as long COVID, or post-COVID-19 syndrome.

Classified as: Lesley Fellows, covid-19, Nancy Mayo, Neurology, Neuro
Published on: 20 Sep 2022

Society recognizes distinguished Canadians who have made remarkable contributions to their academic fields and public life

Two faculty members at The Neuro (Montreal Neurological Institute-Hospital) have been inducted into The Royal Society of Canada (RSC), recognizing their contributions to our understanding of neuroscience and the human brain.

Classified as: Nathan Spreng, Heidi McBride, royal society of canada, Neuro
Published on: 6 Sep 2022

The Neuro joins two other McGill-affiliated organizations in signing The Declaration on Research Assessment

The Neuro (Montreal Neurological Institute-Hospital) has joined the Douglas Research Centre (DRC) and the Canadian Open Neuroscience Platform (CONP) in signing the San Francisco Declaration on Research Assessment (DORA), an agreement that seeks to change how scholarly research contributions are valued in hiring, promotion, and funding decisions.

Classified as: Declaration on Research Assessment, Neuro, Canadian Open Neuroscience Platform, open science, DORA
Published on: 10 Aug 2022

Pages

Back to top